BICALUTAMIDA LABORMED 150mg film-coated tablets medication leaflet

L02BB03 bicalutamide • Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgens

Bicalutamide is an antiandrogen medication primarily used for the treatment of advanced prostate cancer. It works by blocking androgen receptors, thereby reducing the effects of male hormones (testosterone) on prostate cancer cells. It is often used in combination with other therapies, such as gonadotropin-releasing hormone (GnRH) analogs.

Bicalutamide is taken orally, usually once daily, and is well-tolerated by most patients. Common side effects include hot flashes, breast tenderness or enlargement (gynecomastia), fatigue, and nausea. In rare cases, it may affect liver function, so regular liver monitoring is recommended.

The medication is contraindicated in women, especially during pregnancy or breastfeeding, and is not recommended for use in children. It is important for patients to strictly follow their doctor’s instructions and not discontinue treatment without medical advice.

General data about BICALUTAMIDA LABORMED 150mg

Substance: bicalutamide

Date of last drug list: 10-04-2026

Commercial code: W68844001

Concentration: 150mg

Pharmaceutical form: film-coated tablets

Quantity: 28

Product type: generic

Price: 698.93 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: GENEPHARM S.A. - GRECIA

Holder: LABORMED PHARMA S.A. - ROMANIA

Number: 12194/2019/01

Shelf life: 5 years

Concentrations available for bicalutamide

150mg, 50mg

Other substances similar to bicalutamide

Compensation lists for BICALUTAMIDA LABORMED 150mg LABORMED

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

698.93 RON

535.03 RON

163.90 RON